VeriMomIst salix alba extract in der Schwangerschaft sicher?
No EU Annex II/III restriction or harmonised CLP classification was found for Salix alba extract; however the extract contains salicin which is related to salicylic acid and is a class-based concern for systemic salicylate exposure in pregnancy. Regulatory/clinical sources advise caution/avoidance in pregnancy due to salicylate content. ECHA registration lists the extract as a plant extract (not classified). PubMed genotoxicity data do not indicate reproductive teratogenicity for the extract, but clinical guidance (and lactation resources) recommend avoidance because of salicylates. (ECHA registration; PubMed; LactMed; WebMD).
Schwangerschaftssichere Alternativen zu salix alba extract | VeriMom
Related ingredients
Frequently asked questions
- Ist salix alba extract in der Schwangerschaft sicher?
- No EU Annex II/III restriction or harmonised CLP classification was found for Salix alba extract; however the extract contains salicin which is related to salicylic acid and is a class-based concern for systemic salicylate exposure in pregnancy. Regulatory/clinical sources advise caution/avoidance in pregnancy due to salicylate content. ECHA registration lists the extract as a plant extract (not classified). PubMed genotoxicity data do not indicate reproductive teratogenicity for the extract, but clinical guidance (and lactation resources) recommend avoidance because of salicylates. (ECHA registration; PubMed; LactMed; WebMD).
- Ist salix alba extract während des Stillens sicher?
- LactMed and other clinical sources advise avoidance of willow bark/extract during breastfeeding because salicylates can be transferred and aspirin-like compounds have documented neonatal risks; no harmonised CLP or EU ban was found for the extract itself, but clinical precaution is recommended. Topical cosmetic use would give low but measurable exposure depending on formulation and concentration. (LactMed; WebMD; ECHA registration).
- Ist salix alba extract sicher für Babyhaut?
- No specific infant dermal reproductive toxicity data were identified and no harmonised CLP or EU ban applies. Because the extract contains salicylates (which can be systemically active) there is a class-based concern (h=1) and a demonstrated metabolic pathway to salicylic acid (m=2). Dermal exposure in infants is higher relative to adults (immature barrier and higher surface-area-to-weight), so exposure score is increased by +1 for 0–3 yr skin compared with adults. Cosmetic topical use at typical low concentrations likely yields low systemic absorption but infant exposure is higher than adult. (PubMed toxicology summaries; LactMed; ECHA registration).
- Wie bewertet VeriMom salix alba extract?
- VeriMom bewertet salix alba extract mit 60/100 (mittleres Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu salix alba extract?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu salix alba extract basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.